A New King of The GLP-1s Could Be Crowned Cardiac WirePeople with Type 2 diabetes lost up to 60 pounds on Lilly’s latest weight loss drug NBC NewsLilly’s retatrutide: peer-reviewed Phase 3 shows up to 25% weight loss plus knee-pain and sleep-apnoea gains DealroomEli Lilly’s best-ever weight loss data; Sanofi, Regeneron re-up for $1B upfront; and more Endpoints NewsEli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial CNBC